Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Genome wide gene expression studies in mood disorders.

Sequeira A, Turecki G.

OMICS. 2006 Winter;10(4):444-54. Review.

PMID:
17233556
2.

Identifying blood biomarkers for mood disorders using convergent functional genomics.

Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, Tsuang MT, Salomon DR, Nurnberger JI Jr, Niculescu AB.

Mol Psychiatry. 2009 Feb;14(2):156-74. doi: 10.1038/mp.2008.11. Epub 2008 Feb 26. Erratum in: Mol Psychiatry. 2009 Dec;14(12):1143.

PMID:
18301394
3.

Patterns of gene expression in the limbic system of suicides with and without major depression.

Sequeira A, Klempan T, Canetti L, ffrench-Mullen J, Benkelfat C, Rouleau GA, Turecki G.

Mol Psychiatry. 2007 Jul;12(7):640-55. Epub 2007 Mar 13.

PMID:
17353912
4.

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S.

Lancet. 2003 Sep 6;362(9386):798-805.

PMID:
13678875
5.

Gene expression profiling in schizophrenia and related mental disorders.

Iwamoto K, Kato T.

Neuroscientist. 2006 Aug;12(4):349-61. Review.

PMID:
16840711
6.

Genomic landscape of a three-generation pedigree segregating affective disorder.

Yang S, Wang K, Gregory B, Berrettini W, Wang LS, Hakonarson H, Bucan M.

PLoS One. 2009;4(2):e4474. doi: 10.1371/journal.pone.0004474. Epub 2009 Feb 13.

7.

Identification of molecular mechanisms underlying mood stabilization through genome-wide gene expression profiling.

Zhou R, Zarate CA, Manji HK.

Int J Neuropsychopharmacol. 2006 Jun;9(3):263-6. Epub 2005 Oct 6. Review. No abstract available.

PMID:
16207389
8.

Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.

Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, Rouleau GA, Mechawar N, Turecki G.

PLoS One. 2009 Aug 11;4(8):e6585. doi: 10.1371/journal.pone.0006585.

10.

A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction.

Deo AJ, Huang YY, Hodgkinson CA, Xin Y, Oquendo MA, Dwork AJ, Arango V, Brent DA, Goldman D, Mann JJ, Haghighi F.

Psychiatr Genet. 2013 Apr;23(2):47-55. doi: 10.1097/YPG.0b013e32835d7028.

11.

Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder.

Kato T, Ishiwata M, Yamada K, Kasahara T, Kakiuchi C, Iwamoto K, Kawamura K, Ishihara H, Oka Y.

Neurosci Res. 2008 Jun;61(2):143-58. doi: 10.1016/j.neures.2008.02.002. Epub 2008 Feb 14.

PMID:
18343518
12.

Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex.

Tordera RM, Garcia-García AL, Elizalde N, Segura V, Aso E, Venzala E, Ramírez MJ, Del Rio J.

Eur Neuropsychopharmacol. 2011 Jan;21(1):23-32. doi: 10.1016/j.euroneuro.2010.06.016.

PMID:
20937555
13.

Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study.

Brezo J, Bureau A, Mérette C, Jomphe V, Barker ED, Vitaro F, Hébert M, Carbonneau R, Tremblay RE, Turecki G.

Mol Psychiatry. 2010 Aug;15(8):831-43. doi: 10.1038/mp.2009.19. Epub 2009 Apr 21.

PMID:
19381154
14.

A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies.

Chang LC, Jamain S, Lin CW, Rujescu D, Tseng GC, Sibille E.

PLoS One. 2014 Mar 7;9(3):e90980. doi: 10.1371/journal.pone.0090980. eCollection 2014.

15.

[Use of microarrays in the search of gene expression patterns: application to the study of complex phenotypes].

Guindalini C, Tufik S.

Rev Bras Psiquiatr. 2007 Dec;29(4):370-4. Review. Portuguese.

16.

Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes.

Kasahara T, Kubota M, Miyauchi T, Noda Y, Mouri A, Nabeshima T, Kato T.

Mol Psychiatry. 2006 Jun;11(6):577-93, 523.

PMID:
16619054
17.

Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis.

Konradi C.

Brain Res Brain Res Rev. 2005 Dec 1;50(1):142-55. Epub 2005 Jun 20. Review.

PMID:
15964635
18.

Skeletal muscle gene expression profiling in mitochondrial disorders.

Crimi M, Bordoni A, Menozzi G, Riva L, Fortunato F, Galbiati S, Del Bo R, Pozzoli U, Bresolin N, Comi GP.

FASEB J. 2005 May;19(7):866-8. Epub 2005 Feb 23.

PMID:
15728662
19.

Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders.

Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, Choudary PV, Myers RM, Jones EG, Watson SJ, Akil H.

Am J Psychiatry. 2003 Apr;160(4):657-66. Review.

PMID:
12668351
20.

Whole genome/exome sequencing in mood and psychotic disorders.

Kato T.

Psychiatry Clin Neurosci. 2015 Feb;69(2):65-76. doi: 10.1111/pcn.12247. Epub 2014 Nov 9. Review.

Supplemental Content

Support Center